Michael T. Heneka

University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry

Bonn, 53127

Germany

SCHOLARLY PAPERS

4

DOWNLOADS

904

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Defining Microglial States and Nomenclature: A Roadmap to 2030

Number of pages: 44 Posted: 23 Mar 2022
University of Lausanne - Department of Biomedical Sciences, Achucarro Basque Center for Neuroscience, Broad Institute of Harvard and MIT - Stanley Center for Psychiatric Research, University of Victoria, University of Zurich - Institute of Neuropathology, Oregon Health and Science University - Department of Molecular Microbiology and Immunology, Weizmann Institute of Science - Department of Immunology, University of Montpellier - Institut de Génomique Fonctionnelle (IGF), University of Leipzig - Institute of Anatomy, University of Pennsylvania - Children's Hospital of Philadelphia, University of Pennsylvania - Children's Hospital of Philadelphia, École Normale Supérieure (ENS), AbbVie Deutschland GmbH & Co. KG - Neuroscience Discovery, Duke University - Department of Psychology and Neuroscience, University of California, Irvine - Center for the Neurobiology of Learning and Memory, University of Groningen - Department of Biomedical Sciences of Cells & Systems, University of Lisbon - Research Institute for Medicines (iMed.ULisboa), Hasselt University - Biomedical Research Institute, University of Cambridge - Department of Biochemistry, Harvard University - Ann Romney Center for Neurologic Diseases, University of California, Riverside (UCR) - Center for Glial-Neuronal Interactions, Fisiología e Inmunología - Unidad de Histología Medica, Washington University in St. Louis - Department of Pathology and Immunology, University of Oxford - James and Lillian Martin Centre for Stem Cell Research, Trinity College (Dublin) - School of Biochemistry & Immunology, Cleveland Clinic - Department of Neurosciences, Columbia University - Center for Translational and Systems Neuroimmunology, University College London - Bart de Strooper, Hungarian Academy of Sciences (HAS) - “Momentum” Laboratory of Neuroimmunology, University of Groningen - Department of Biomedical Sciences of Cells & Systems, Mayo Clinic - Department of Neurology, Autonomous University of Barcelona - Institut de Neurociències and Departament de Bioquímica, École Normale Supérieure - PSL Research University - Institute of Biology of the Ecole Normale Supérieure (IBENS), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), University of California, San Diego (UCSD) - Department of Cellular & Molecular Medicine, Ludwig Maximilian University of Munich (LMU) - Institute for Stroke and Dementia Research, University of Southampton - School of Biological Sciences, Fisiología e Inmunología - Unidad de Histología Medica, University of Oxford - Sir William Dunn School of Pathology, The University of Sydney - Ken Parker Brain Tumour Research Laboratories, Brain and Mind Centre, University of Manchester - Lydia Becker Institute of Immunology and Inflammation, University of Paris - INSERM, University of Zurich - Institute of Experimental Immunology, Washington University in St. Louis - School of Medicine, Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, Charité - Universitätsmedizin Berlin - Institute for Neuropathology, University College London - UK Dementia Research Institute, Weizmann Institute of Science - Department of Immunology, Max-Delbrück Center for Molecular Medicine, University of Virginia - Department of Neuroscience, University of Tokyo - Laboratory of Chemical Pharmacology, Salk Institute for Biological Studies - Molecular Neurobiology Laboratory, Trinity College (Dublin) - Institute of Neuroscience, University of Rochester - Department of Neuroscience, King's College London - Wolfson Centre for Age-Related Diseases, University of Eastern Finland - A.I. Virtanen Institute for Molecular Sciences, University of Antwerp - Department of Biomedical Sciences, Humanitas University - Department of Biomedical Sciences, UK Dementia Research Institute, University of Edinburgh - MRC Centre for Reproductive Health, University of California, San Francisco (UCSF), University of California, Berkeley - Howard Hughes Medical Institute (HHMI), Discovery Pharmacology - Roche Innovation Center Zurich, University of Bordeaux - Neurocentre Magendie, German Center for Neurodegenerative Diseases (DZNE), Vilnius University - VU LSC-EMBL Partnership for Genome Editing Technologies, University of Bonn - Institute of Reconstructive Neurobiology, Kyushu University - Laboratory of Pathophysiology, Fudan University - Department of Neurosurgery, University of Zurich - Department of Molecular Life Sciences, UK Dementia Research Institute, Ohio State University (OSU) - Department of Neuroscience, Technische Universität München (TUM) - Department of Psychiatry & Psychotherapy, University of Rome I - Department of Physiology and Pharmacology, Third Rock Ventures, The Hospital for Sick Children, Mount Sinai Health System - Nash Department of Neuroscience, University of Massachusetts Worcester - Department of Neurobiology, Weizmann Institute of Science - Department of Neurobiology, German Center for Neurodegenerative Diseases (DZNE) - Institute of Neuronal Cell Biology, University of Florida - Division of Neuroscience, University of Freiburg - Faculty of Biology, Massachusetts Institute of Technology (MIT) - The Picower Institute for Learning and Memory, Celica Biomedical, Universidad San Sebastian - Faculty of Health Sciences, Nagoya University - Department of Anatomy and Molecular Cell Biology, Université Libre de Bruxelles (ULB) - Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Charité Universitätsmedizin Berlin, Mayo Clinic - Department of Neurology and Stanford University - Department of Neurology and Neurological Sciences
Downloads 789 (45,574)

Abstract:

Loading...

2.

PLCG2 Protective Variant p.P522R Modulates Tau Pathology and Disease Progression in Patients with Mild Cognitive Impairment

Number of pages: 83 Posted: 02 Jan 2019
University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, University of Bonn - Institute of Innate Immunity, VU University Amsterdam - Department of Neurology, Andalusian Bioinformatics Research Centre (CAEBi), University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Paris-Saclay, University of Cologne - Division of Neurogenetics and Molecular Psychiatry, University of Erlangen-Nuremberg-Friedrich Alexander Universität Erlangen Nürnberg, University of Lausanne - Department of Psychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, VU University Amsterdam - Department of Neurology, VU University Amsterdam - Department of Neurology, University of Erlangen-Nuremberg-Friedrich Alexander Universität Erlangen Nürnberg, Charité - Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, University of Montpellier, University of Bonn, Faculty of Medicine, Department of Psychiatry and Psychotherapy, Heidelberg University - Central Institute of Mental Health, University of Bordeaux - Bordeaux Population Health Research Center, University of Bordeaux - Bordeaux Population Health Research Center, University of Freiburg - Department of Rehabilitation Psychiatry and Psychotherapy, Universitat Internacional de Catalunya, Carlos III Institute of Health, Carlos III Institute of Health, Universitat Internacional de Catalunya, Universitat Internacional de Catalunya, VU University Amsterdam - Amsterdam Public Health Research Institute, University of Amsterdam - Amsterdam Public Health Research Institute, VU University Amsterdam - Amsterdam Public Health Research Institute, VU University Amsterdam - Department of Neurology, University of Goettingen (Gottingen), Faculty of Medicine, University Medical Centre, Department of Psychiatry and Psychotherapy, University of Paris-Saclay, University of Goettingen (Gottingen), Faculty of Medicine, University Medical Centre, Department of Psychiatry and Psychotherapy, Universitat Internacional de Catalunya, German Center for Neurodegenerative Diseases (DZNE), University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Leipzig - Institute for Social Medicine, Occupational Health and Public Health, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, German Center for Neurodegenerative Diseases (DZNE), Carlos III Institute of Health, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, Andalusian Bioinformatics Research Centre (CAEBi), University of Bonn - Institute of Innate Immunity, University of Bonn, Faculty of Medicine, Department of Psychiatry and Psychotherapy, University of Lille II - RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, VU University Amsterdam - Department of Neurology, Andalusian Bioinformatics Research Centre (CAEBi), German Center for Neurodegenerative Diseases (DZNE)University of Bonn - Institute of Innate Immunity, Universitat Internacional de Catalunya and University of Cologne - Division of Neurogenetics and Molecular Psychiatry
Downloads 92 (388,723)

Abstract:

Loading...

3.

Amyloid β Clustering Around ASC Fibrils Boost Its Toxicity in Microglia

Number of pages: 36 Posted: 21 Oct 2019
University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, University of Bonn - Institute of Structural Biology, University of Bonn - Institute of Structural Biology, Max Planck Institute for Biophysical Chemistry - Department of Structural Dynamics, German Center for Neurodegenerative Diseases (DZNE)University of Bonn - Institute of Innate Immunity, University of Bonn - Institute of Structural Biology and University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry
Downloads 14 (768,537)

Abstract:

Loading...

ASC, Aβ, microglia, NLRP3 inflammasome, Alzheimer's disease

4.

Microglial NLRP3 Inflammasome Activation Upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies

Number of pages: 35 Posted: 21 Sep 2020
University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, CEA - Institut François Jacob, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases (DZNE)University of Bonn - Institute of Innate Immunity, CEA - Institut François Jacob and University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry
Downloads 9 (818,180)

Abstract:

Loading...

microglia, α-synuclein, NLRP3 inflammasome, Toll-like receptors, clearance